
Loading Pathway...
Error: Pathway image not found.
Hide
Pathway Description
Halothane NMDA Antagonist Action Pathway
Homo sapiens
Drug Action Pathway
Halothone is a general inhalation anesthetic used for the induction and maintenance of general anaesthesia. It provides relatively rapid infuction with little or no excitement. Halothane may not produce sufficient muscle relaxation, so supplemental neuromuscular blocking agents may be required as well.
Halothone is diffused across the blood-brain barrier after being inhaled. It then antagonizes NMDA receptors in the brain. This prevents glutamate from binding to NMDA receptors as readily. This prevents calcium from entering the postsynaptic neuron which leads to hyperpolarization. This hyperpolarization of neurons causes an anaesthetic effect.
References
Halothane NMDA Antagonist Pathway References
Wishart DS, Feunang YD, Guo AC, Lo EJ, Marcu A, Grant JR, Sajed T, Johnson D, Li C, Sayeeda Z, Assempour N, Iynkkaran I, Liu Y, Maciejewski A, Gale N, Wilson A, Chin L, Cummings R, Le D, Pon A, Knox C, Wilson M: DrugBank 5.0: a major update to the DrugBank database for 2018. Nucleic Acids Res. 2018 Jan 4;46(D1):D1074-D1082. doi: 10.1093/nar/gkx1037.
Pubmed: 29126136
Perouansky M, Kirson ED, Yaari Y: Halothane blocks synaptic excitation of inhibitory interneurons. Anesthesiology. 1996 Dec;85(6):1431-8; discussion 29A. doi: 10.1097/00000542-199612000-00025.
Pubmed: 8968191
Bovill JG: Inhalation anaesthesia: from diethyl ether to xenon. Handb Exp Pharmacol. 2008;(182):121-42. doi: 10.1007/978-3-540-74806-9_6.
Pubmed: 18175089
Highlighted elements will appear in red.
Highlight Compounds
Highlight Proteins
Enter relative concentration values (without units). Elements will be highlighted in a color gradient where red = lowest concentration and green = highest concentration. For the best results, view the pathway in Black and White.
Visualize Compound Data
Visualize Protein Data
Downloads
Settings